{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:45:17Z","timestamp":1790066717902,"version":"4.0.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T00:00:00Z","timestamp":1242864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0005656","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T18:36:02Z","timestamp":1242844562000},"page":"e5656","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":165,"title":["Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study\u2014Secondary Analysis of the Randomized Trial"],"prefix":"10.1371","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct00518167","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Matti","family":"Uusitupa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Aunola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirjo","family":"Ilanne-Parikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Kein\u00e4nen-Kiukaanniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo T.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan G.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Finnish Diabetes Prevention Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T","article-title":"Glucose: a continuous risk factor for cardiovascular disease.","volume":"14","author":"HC Gerstein","year":"1997","journal-title":"Diabet Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.","volume":"321","author":"IM Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2337\/diacare.28.12.2901","article-title":"Type 2 Diabetes as a \u201cCoronary Heart Disease Equivalent\u201d: An 18-year prospective population-based study in Finnish subjects.","volume":"28","author":"A Juutilainen","year":"2005","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.","volume":"20","author":"XR Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.","volume":"344","author":"J Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).","volume":"49","author":"A Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabres.2004.06.010","article-title":"Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.","volume":"67","author":"K Kosaka","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: The follow-up results of the Finnish Diabetes Prevention Study.","volume":"368","author":"J Lindstr\u00f6m","year":"2006","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.","volume":"371","author":"G Li","year":"2008","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.","volume":"359","author":"J-L Chiasson","year":"2002","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.","volume":"51","author":"TA Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.","volume":"368","author":"HC Gerstein","year":"2006","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","article-title":"The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.","volume":"26","author":"J Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/dc07-1117","article-title":"Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study.","volume":"31","author":"P Ilanne-Parikka","year":"2008","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.309.6946.23","article-title":"Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland.","volume":"309","author":"E Vartiainen","year":"1994","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s001250051229","article-title":"Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.","volume":"42","author":"J Eriksson","year":"1999","journal-title":"Diabetologia"},{"key":"ref18","article-title":"Diabetes Mellitus: Report of a WHO Study Group. Geneva.","year":"1985"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1007380408729","article-title":"Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland.","volume":"13","author":"JM Rapola","year":"1997","journal-title":"Eur J Epidemiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0895-4356(98)00145-0","article-title":"The validity of the routine mortality statistics on coronary heart disease in Finland: comparison with the FINMONICA MI register data for the years 1983\u20131992. Finnish multinational MONItoring of trends and determinants in CArdiovascular disease.","volume":"52","author":"M M\u00e4h\u00f6nen","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles.","volume":"121","author":"KM Anderson","year":"1991","journal-title":"Am Heart J"},{"key":"ref22","article-title":"Stata Statistical Software: Release 9.2","year":"2005"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s001250051024","article-title":"No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise.","volume":"41","author":"KF Eriksson","year":"1998","journal-title":"Diabetologia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/BF00401063","article-title":"Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.","volume":"36","author":"MI Uusitupa","year":"1993","journal-title":"Diabetologia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects.","volume":"357","author":"L Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program.","volume":"28","year":"2005","journal-title":"Diabetes Care"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0005656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:04:57Z","timestamp":1540245897000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0005656"}},"subtitle":[],"editor":[{"given":"Thorkild I. A.","family":"Sorensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,5,21]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0005656","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,21]]}}}